CARDIOVASCULAR  INNOVATIONS  FOUNDATION

CVI Webinar Series: Coronary Physiology and Imaging: Step-By-Step

March 11, 2021 – March 11, 2022

TARGET AUDIENCE

This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, and allied health care workers who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.

EDUCATIONAL GOAL

The goal of this activity is to provide participants with knowledge and state-of-the-art management information on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.

LEARNING OBJECTIVES

  • Describe step-by-step performance of coronary physiology and imaging with IVUS and OCT for assessing coronary lesions
  • Explain the coronary physiology and imaging for determining lesion significance
  • Identify coronary physiology and imaging to optimize the outcomes of PCI

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this enduring internet activity for a maximum of 1 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Start Date: March 11, 2021                            End Date: March 11, 2022

FEES

There is no registration fee for this activity.

PARTICIPATION REQUIREMENTS

  1. View webinar
  2. At the end of the webinar, login to: https://online-med-edu.com/cvi2021/webinar/coronaryphys (you are here)
  3. Complete the Evaluation/Credit Request Form
  4. Download or Print Credit Statement

FACULTY AND DISCLOSURES

CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.

Emmanouil S. Brilakis, MD, PhD
Director, Center for Complex Coronary Interventions, Minneapolis Heart institute
Minneapolis, MN
Has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, CSI, GE Healthcare-Consultant, Speaker's Bureau; Amgen, Infra Redx, Teleflex-Speaker Bureau; Regeneron, Siemens Healthineers-Research Grant, Speaker's Bureau; Elsevier-Consultant

Chadi Alraies, MD, MPH
Director, Interventional Cardiology Research, Detroit Medical Center
Detroit, MI
Has disclosed the following relevant financial relationships: Cardiovascular Systems, Abiomed-Consultant

Matthew Price, MD
Director, Cardiac Catheterization Laboratory, Division of Cardiovascular Diseases, Scripps Health
San Diego, CA
Has disclosed the following relevant financial relationships: Abbott Vascular, Medtronic, Boston Scientific, Shockwave Medical-Speaker, Consultant

Arnold Seto, MD
Chief of Cardiology, Long Beach VA Medical Center
Long Beach, CA
Has disclosed the following relevant financial relationships: Acist Medical, Philips-Research Grants to Institution; Terumo, General Electric, Janssen-Speaker, Teacher

Evan Shlofmitz, DO
Interventional Cardiology Fellow, MedStar Washington Hospital Center
Washington, DC
Has disclosed the following relevant financial relationships:  Abbott Vascular, Opsens-Consultant

Planner Disclosures

No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose.

Off-label Use

This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for this educational activity will be provided by the following:

  • Boston Scientific
  • Medtronic
  • Philips

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org .


 complete evaluation/credit request